Day: October 15, 2020

Seoul Skyline

Navigating Drug Approvals and Post-Approval Changes in the Asia-Pacific Region

At the FDA/Xavier PharmaLink conference held virtually in March 2020, AbbVie’s Debra Webb shared her experiences and provided expert advice on navigating the various processes in several APAC markets. Webb discussed her experiences with queries from various agencies during the drug approval process and provides a case study on a post-approval change in South Korea.

Read More »

Can’t find what you are looking for? Contact us.